<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "niMODipine tab">
<dose><value>60</value>
<value>90</value>
<value>30</value>
</dose>
<route><value>PO</value>
</route>
<strength><value>30 mg</value>
</strength>
<frequency><value>Q4H</value>
</frequency>
<instruction><value>for 21 consecutive days after diagnosis of SAH.</value>
</instruction>
<volume></volume>
<units><value>mg</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Consideration in patients with hepatic insufficency due to substantially reduced clearance and approximately doubled maximum plasma concentrations.</value>
</AdditionalNotes>
<BackgroundInformation></BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary.</value>
</AHSFormularyStatus>
<AHFSName><value>Calcium-Channel Blocking Agents, Dihydropyridines</value>
</AHFSName>
<HighAlert></HighAlert>
</drug>